Surrozen (SRZN)

• Market cap: $288M
• 1 day: -5.2%
• 5 days: -7.7%
• 1 month: -21.42%
• 3 months: -13.29%
• 6 months: 53.85%
• Year to date: 15.08%
• 1 year: 192.45%
• 5 years: -83.21%
• 10 years: -83.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Employees: 44